Pain physician · 2011
Intramuscular botulinum toxin A (BtxA) in complex regional pain syndrome.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kharkar Siddharth, Ambady Prakash, Yedatore Venkatesh, Schwartzman Robert J
Аннотация
BACKGROUND: Pain associated with complex regional pain syndrome (CRPS) is frequently excruciating and intractable. The use of botulinum toxin for relief of CRPS-associated pain has not been well described.
OBJECTIVES: To assess whether intramuscular botulinum toxin injections cause relief of pain caused by CRPS, and to assess the risks of this treatment.
STUDY DESIGN: Retrospective chart review.
SETTING: Outpatient clinic.
PATIENTS: 37 patients with spasm/dystonia in the neck and/or upper limb girdle muscles.
INTERVENTION: Electromyography-guided injection of botulinum toxin A (BtxA), 10-20 U per muscle. Total dose used was 100 U in each patient.
MEASUREMENT: Local pain score on an 11 point Likert scale, 4 weeks after BtxA injections.
RESULTS: Mean pain score decreased by 43% (8.2 ± 0.8 to 4.5 ± 1.1, P < 0.001). Ninety-seven percent of the patients had significant pain relief. One patient had transient neck drop after the injections.
LIMITATIONS: This is a retrospective study; it lacks a control group and therefore the placebo effect cannot be eliminated. This study does not provide information on the efficacy of this treatment after 4 weeks.
CONCLUSION(S): Intramuscular injection of botulinum toxin A in the upper limb girdle muscles was beneficial for short term relief of pain caused by CRPS in this retrospective case series. The incidence of complications was low (2.7%).
OBJECTIVES: To assess whether intramuscular botulinum toxin injections cause relief of pain caused by CRPS, and to assess the risks of this treatment.
STUDY DESIGN: Retrospective chart review.
SETTING: Outpatient clinic.
PATIENTS: 37 patients with spasm/dystonia in the neck and/or upper limb girdle muscles.
INTERVENTION: Electromyography-guided injection of botulinum toxin A (BtxA), 10-20 U per muscle. Total dose used was 100 U in each patient.
MEASUREMENT: Local pain score on an 11 point Likert scale, 4 weeks after BtxA injections.
RESULTS: Mean pain score decreased by 43% (8.2 ± 0.8 to 4.5 ± 1.1, P < 0.001). Ninety-seven percent of the patients had significant pain relief. One patient had transient neck drop after the injections.
LIMITATIONS: This is a retrospective study; it lacks a control group and therefore the placebo effect cannot be eliminated. This study does not provide information on the efficacy of this treatment after 4 weeks.
CONCLUSION(S): Intramuscular injection of botulinum toxin A in the upper limb girdle muscles was beneficial for short term relief of pain caused by CRPS in this retrospective case series. The incidence of complications was low (2.7%).